Evolus, Inc. Share Price & Technical Analysis
EOLS · $6.09 (-5.58%)
Healthcare / Drug Manufacturers - Specialty & Generic
$6.09
-5.58%
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, …
Price chart
Seasonality
May has 4 positive and 1 negative years (last 5 years shown)
13% return in May, -3% avg return in past 3 year May month.
6% return in 2026, 6% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -30% | -7% | -2% | 32% | 13% | – | – | – | – | – | – | – | 6% |
| 25 | 26% | 7% | -18% | -4% | -19% | 0% | -3% | -15% | -20% | 5% | 11% | -6% | -36% |
| 24 | 21% | 15% | -5% | -16% | 7% | -16% | 15% | 14% | 2% | 1% | -16% | -18% | 2% |
| 23 | 37% | -12% | -7% | 4% | 5% | -19% | 37% | -2% | -9% | -16% | 25% | 11% | 52% |
| 22 | 14% | 23% | 26% | -1% | 16% | -10% | 6% | -22% | -15% | 6% | -16% | 4% | 31% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Uptrend
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$422.13M
P/E ratio
—
52W high
$10.62
52W low
$3.86
Volume
6,11,119
Beta
1.29
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Evolus, Inc. share price today?
- Evolus, Inc. (EOLS) last traded around $6.09 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does EOLS have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for EOLS. Download the app for real-time alerts.
- How can I analyze Evolus, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.